Sarcopenia in idiopathic pulmonary fibrosis (IPF): Prevalence and response to pulmonary rehabilitation (PR)

C. Nolan (London, United Kingdom), M. Maddocks (London, United Kingdom), T. Maher (London, United Kingdom), S. Patel (London, United Kingdom), R. Barker (London, United Kingdom), J. Walsh (London, United Kingdom), O. Polgar (London, United Kingdom), P. George (London, United Kingdom), W. Man (London, United Kingdom)

Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation
Session: Optimising the benefits of pulmonary rehabilitation
Session type: E-poster session
Number: 887
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Nolan (London, United Kingdom), M. Maddocks (London, United Kingdom), T. Maher (London, United Kingdom), S. Patel (London, United Kingdom), R. Barker (London, United Kingdom), J. Walsh (London, United Kingdom), O. Polgar (London, United Kingdom), P. George (London, United Kingdom), W. Man (London, United Kingdom). Sarcopenia in idiopathic pulmonary fibrosis (IPF): Prevalence and response to pulmonary rehabilitation (PR). 887

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: